Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 4 , Pages 410-413, December 2007

Factors Influencing the Postpartum Length of Hospital Stay in Eclamptic Women

Zekai Tahir Burak Woman Health Education and Research Hospital, Ankara, Turkey

Accepted 11 June 2007.

Article Outline

SUMMARY 

Objective

To determine which variables are associated with postpartum length of hospital stay in eclamptic patients.

Materials and Methods

The study sample comprised 98 eclamptic patients who were admitted to our perina-tology unit during the period between January 1998 and May 2003. The study sample was divided into two postpartum length-of-stay groups: the short-stay group (1–3 days) consisted of 33 patients and the long-stay group (4 days and longer) consisted of 65 patients. The groups were compared with respect to the demographic characteristics, clinical and laboratory variables, and complications.

Results

The mean hospitalization periods for the short-stay and long-stay groups were 2.48 ± 0.79 and 5.60 ±2.12 days, respectively (p=0.010). The mean prepartum follow-up period after the onset of eclampsia was longer in the long-stay group than in the short-stay group (12.11 ±27.63 vs. 5.08 ± 6.08 hours). The proportion of patients receiving magnesium sulfate therapy longer than 12 hours was higher in the long-stay group (p = 0.014). The long-stay group had higher diastolic arterial blood pressure than that of the short-stay group (p=0.006). The total cesarean delivery rate for the short-stay group was 48.5%, compared with 67.7% in the long-stay group (p=0.081). Conclusion: The duration of magnesium therapy, the timing, and the mode of delivery should be individualized to reduce the length of hospital stay in eclamptic patients.

Key Words:  eclampsia , hospital stay

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. ACOG Committee on Obstetric Practice  , ACOG practice bulletin  . Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists . Int J Gynaecol Obstet . 2002;77:67–75
  2. Cunningham FG , Gant NF , Leveno KJ , Gilstrap LC , Hauth JC , Wenstrom KD . Hypertensive disorders in pregnancy . In:  Cunningham FG ,  Gant NF ,  Leveno KJ ,  Gilstrap LC ,  Havth JC ,  Wenstrom KD editor. Williams Obstetrics . 21st edition. New York: McGraw-Hill; 2001;p. 567–618
  3. Mattar F , Sibai BM . Eclampsia. VIII. Risk factors for maternal morbidity . Am J Obstet Gynecol . 2000;182:307–312
  4. Lenfant C . Working group report on high blood pressure in pregnancy . J Clin Hypertens (Greenwich) . 2001;3:75–88
  5. Dildy GA , Cotton DB , Phelan JP . Complications of pregnancy-induced hypertension . In:  Clark SL ,  Cotton DB ,  Hankins GDV ,  Phelan JP editor. Critical Care Obstetrics . 2nd edition. Boston: Blackwell Scientific; 1991;p. 251–288
  6. Cunningham FG , Gant NF . Management of eclampsia . Semin Perinatol . 1994;18:103–113
  7. The Eclampsia Trial Collaborative Group . Which anti-convulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial . Lancet . 1995;345:1455–1463
  8. Isler CM , Barrilleaux PS , Rinehart BK , Magann EF , Martin JN . Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy . Obstet Gynecol . 2003;101:66–69
  9. Ascarelli MH , Johnson V , May WL , Martin RW , Martin JN . Individually determined postpartum magnesium sulfate therapy with clinical parameters to safely and cost-effectively shorten treatment for pre-eclampsia . Am J Obstet Gynecol . 1998;179:952–956
  10. Fontenot MT, Lewis DF, Frederick JB, Wang Y, DeFranco EA, Groome LJ, et al. A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of post-partum therapy . Am J Obstet Gynecol . 2005;192:1788–1793 discussion 1793-4.
  11. Duley L . Evidence and practice: the magnesium sulphate story . Best Pract Res Clin Obstet Gynaecol . 2005;19:57–74
  12. Ekele BA , Ahmed Y . Magnesium sulfate regimens for eclampsia . Int J Gynaecol Obstet . 2004;87:149–150
  13. Vigil-De Gracia P , Garcia-Caceres E . Thrombocytopenia, hypertension and seizures in eclampsia . Int J Gynaecol Obstet . 1998;61:15–20
  14. Usta IM , Sibai BM . Emergent management of puerperal eclampsia . Obstet Gynecol Clin North Am . 1995;22:315–335
  15. Haddad B , Barton JR , Livingston JC , Chahine R , Sibai BM . Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome . Am J Obstet Gynecol . 2000;183:444–448

PII: S1028-4559(08)60012-1

doi:10.1016/S1028-4559(08)60012-1

Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 4 , Pages 410-413, December 2007

Article Tools